SCHEMBL6537639

SCHEMBL6537639

O=C(Nc1cc(C(F)(F)F)cc2c(-n3ccnc3)ccnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 7/20 0.46
ALDH1A1 P00352 1/20 0.46
PTGES O14684 1/20 0.44
TYK2 P29597 2/20 0.41
TLR7 Q9NYK1 2/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
ATR Q13535 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
IDH2 P48735 2/20 0.39
TLR8 Q9NR97 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537494 0.89 CD38 (0.46) CD38PTGESTYK2CYP1A2CYP2C19
SCHEMBL6537403 0.88 CD38 (0.45) CD38TYK2CYP1A2CYP2C19CYP3A4
SCHEMBL6538101 0.87 CYP3A4 (0.46) CD38TYK2CYP1A2CYP2C19CYP3A4
SCHEMBL6537488 0.85 CYP3A4 (0.48) CD38TYK2CYP1A2CYP2C19CYP3A4
SCHEMBL6538167 0.84 PTGES (0.51) PTGESTYK2TLR7CYP3A4JAK2
SCHEMBL6537983 0.80 PTGES (0.50) PTGESTYK2TLR7JAK2JAK1
SCHEMBL8471112 0.79 PTGES (0.41) PTGESTYK2TLR7JAK2JAK1
SCHEMBL6537819 0.78 CYP3A4 (0.45) CD38TYK2CYP1A2CYP2C19CYP3A4
SCHEMBL6537684 0.78 CYP3A4 (0.48) CD38TYK2CYP1A2CYP2C19CYP3A4
SCHEMBL6537943 0.78 CYP3A4 (0.47) CD38TYK2CYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed